OAKLAND, Calif.–(BUSINESS WIRE)–Sonalasense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001 in combination with Insightec’s MR-guided focused ultrasound (MRgFUS), today announced that the first cohort in SDT-202 was fully enrolled.
Read more here.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://blog.ourcrowd.com/sonalasense-announces-completion-of-first-cohort-in-phase-2-study-of-sonala-001-sonodynamic-therapy-for-recurrent-glioblastoma/